HK1147100A1 - Monosebacate of pyrazole derivative - Google Patents

Monosebacate of pyrazole derivative

Info

Publication number
HK1147100A1
HK1147100A1 HK11101141.3A HK11101141A HK1147100A1 HK 1147100 A1 HK1147100 A1 HK 1147100A1 HK 11101141 A HK11101141 A HK 11101141A HK 1147100 A1 HK1147100 A1 HK 1147100A1
Authority
HK
Hong Kong
Prior art keywords
monosebacate
dimethylpropionamide
methylphenoxy
pyrazol
ylmethyl
Prior art date
Application number
HK11101141.3A
Other languages
English (en)
Inventor
Hideki Takeuchi
Eiji Tsuru
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of HK1147100A1 publication Critical patent/HK1147100A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK11101141.3A 2007-12-27 2011-02-02 Monosebacate of pyrazole derivative HK1147100A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007337985 2007-12-27
PCT/JP2008/073405 WO2009084531A1 (ja) 2007-12-27 2008-12-24 ピラゾール誘導体のモノセバシン酸塩

Publications (1)

Publication Number Publication Date
HK1147100A1 true HK1147100A1 (en) 2011-07-29

Family

ID=40824245

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11101141.3A HK1147100A1 (en) 2007-12-27 2011-02-02 Monosebacate of pyrazole derivative

Country Status (16)

Country Link
US (1) US8399418B2 (pt)
EP (1) EP2228378B1 (pt)
JP (1) JP5144683B2 (pt)
KR (1) KR101416561B1 (pt)
CN (1) CN101910189B (pt)
AU (1) AU2008344436B2 (pt)
BR (1) BRPI0821773B8 (pt)
CA (1) CA2709530C (pt)
ES (1) ES2548578T3 (pt)
HK (1) HK1147100A1 (pt)
IL (1) IL206576A (pt)
MX (1) MX2010007154A (pt)
NZ (1) NZ586336A (pt)
RU (1) RU2482122C2 (pt)
TW (1) TWI426914B (pt)
WO (1) WO2009084531A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2725230C (en) * 2008-04-16 2016-05-17 Kissei Pharmaceutical Co., Ltd. Hemifumarate of a pyrazole derivative
WO2011002001A1 (ja) * 2009-07-01 2011-01-06 キッセイ薬品工業株式会社 ピラゾール誘導体とビグアナイド薬との組み合わせ医薬
WO2011002012A1 (ja) * 2009-07-01 2011-01-06 大日本住友製薬株式会社 Sglt1阻害薬とインスリン抵抗性改善薬を組み合わせてなる医薬
JPWO2011002011A1 (ja) * 2009-07-01 2012-12-13 キッセイ薬品工業株式会社 Ｓｇｌｔ１阻害薬とｄｐｐ−ｉｖ阻害薬を組み合わせてなる医薬
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN104284665B (zh) * 2012-05-07 2016-11-16 橘生药品工业株式会社 吡唑衍生物及其医药用途
UA113086C2 (xx) 2012-05-10 2016-12-12 Піразольні сполуки як інгібітори sglt1
TW201425326A (zh) 2012-10-05 2014-07-01 Lilly Co Eli 新穎脲化合物
ES2694110T3 (es) 2013-02-04 2018-12-18 Taisho Pharmaceutical Co., Ltd. Fármaco profiláctico o terapéutico para el estreñimiento
AR098670A1 (es) 2013-11-08 2016-06-08 Lilly Co Eli Inhibidor de sglt1
CA3094118A1 (en) 2018-03-28 2019-10-03 Avolynt Method for treating post-prandial hypoglycemia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1238363C (zh) * 2000-12-28 2006-01-25 橘生药品工业株式会社 吡喃葡糖氧基吡唑衍生物及其在药物中的应用
KR100985502B1 (ko) * 2002-08-08 2010-10-05 깃세이 야쿠힌 고교 가부시키가이샤 피라졸 유도체,그것을 함유하는 의약 조성물, 그 의약용도 및 그 제조 중간체
CN100413878C (zh) * 2002-08-23 2008-08-27 橘生药品工业株式会社 吡唑衍生物、含该衍生物的医药组合物、其医药用途及用于制备的中间体
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
AU2003262262A1 (en) * 2002-08-27 2004-03-19 Kissei Pharmaceutical Co., Ltd. Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
JP2007516155A (ja) * 2003-10-14 2007-06-21 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ エストロゲン活性を有する（３ｒ，４ｒ）−トランス−３，４−ジアリールクロマン誘導体
US20060111560A1 (en) 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
EP1846003A1 (en) * 2005-01-14 2007-10-24 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. 9a-carbamoyl and thiocarbamoyl azalides with anti-inflammatory activity
CN101146791B (zh) * 2005-01-21 2013-01-09 阿斯泰克斯治疗有限公司 作为激酶抑制剂的4-(2，6-二氯-苯甲酰基氨基)-1h-吡唑-3-甲酸哌啶-4-基酰胺的酸加成盐
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
US8343953B2 (en) * 2005-06-22 2013-01-01 Astex Therapeutics Limited Pharmaceutical compounds
UY30082A1 (es) * 2006-01-11 2007-08-31 Boehringer Ingelheim Int Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos

Also Published As

Publication number Publication date
US20100279962A1 (en) 2010-11-04
EP2228378A4 (en) 2014-05-28
CN101910189B (zh) 2013-06-19
WO2009084531A1 (ja) 2009-07-09
NZ586336A (en) 2011-06-30
BRPI0821773A2 (pt) 2015-06-16
TW200934504A (en) 2009-08-16
MX2010007154A (es) 2010-10-05
BRPI0821773B8 (pt) 2021-05-25
AU2008344436A1 (en) 2009-07-09
CA2709530C (en) 2016-02-23
BRPI0821773B1 (pt) 2020-05-19
RU2482122C2 (ru) 2013-05-20
CN101910189A (zh) 2010-12-08
IL206576A (en) 2014-02-27
IL206576A0 (en) 2010-12-30
EP2228378A1 (en) 2010-09-15
CA2709530A1 (en) 2009-07-02
JP5144683B2 (ja) 2013-02-13
RU2010126230A (ru) 2011-12-27
KR20100102140A (ko) 2010-09-20
US8399418B2 (en) 2013-03-19
KR101416561B1 (ko) 2014-07-08
JPWO2009084531A1 (ja) 2011-05-19
EP2228378B1 (en) 2015-09-09
TWI426914B (zh) 2014-02-21
AU2008344436B2 (en) 2013-08-29
ES2548578T3 (es) 2015-10-19

Similar Documents

Publication Publication Date Title
HK1147100A1 (en) Monosebacate of pyrazole derivative
ES2487616T3 (es) Derivados de benzofurano
GB0719180D0 (en) New process
TNSN08372A1 (en) Heterocyclic amides for use as pharmaceuticals
TW200914429A (en) Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
RS51341B (en) INTERMEDIATE COMPOUNDS FOR THE TRANS-5-CHLOR-2-METHYL-2,3A, 12B-TETRAHYDRO-1H-DIBENZE [2,3; 6,7] OXEPINO [4,5-C] Pyrrole
WO2008080504A3 (de) Substituierte 1-(3-pyridinyl)pyrazol-4-yl-essigsäuren, verfahren zu deren herstellung und deren verwendung als herbizide und pflanzenwachstumsregulatoren
TN2009000024A1 (en) Prodrug of cinnamide compound
EA200870362A1 (ru) Способ получения производных лактамида, новые производные лактамида и препараты, содержащие производные лактамида
WO2007112914A3 (en) Ceramide kinase modulation
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
GB0601744D0 (en) Organic compounds
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
ATE545634T1 (de) Aromatisches säureether-derivat aus ligustrazin, herstellungsverfahren, pharmazeutische zusammensetzung und anwendung
MX2012004886A (es) Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas.
CY1111308T1 (el) Παρασκευη εσλικαρβαζεπινης και σχετικων ενωσεων με ασυμμετρη υδρογονωση
IL204936A0 (en) Preparation of dihydropyrrol derivatives as intermediates
ATE411994T1 (de) Herstellung eines substituierten chinoxalins von hoher reinheit
DK2285765T3 (da) Fremgangsmåde til fremstilling af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre
TN2010000072A1 (en) New compounds
WO2009028676A1 (ja) カルボニル化合物の製造方法およびカルボニル化合物の製造に用いる酸化促進剤
WO2009001203A3 (en) An improved process for the preparation of aprepitant
BR112013015604A2 (pt) novo derivado de isoquinolina substituído
TW200619201A (en) Process for the preparation of pyrazoles
MX2012007836A (es) Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida.